跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
!!Search content at 國立陽明交通大學研發優勢分析平台
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
Pei Chen Yu
, Chen Hao Huang
, Chih Jung Kuo
, Po Huang Liang
, Lily Hui Ching Wang
, Max Yu Chen Pan
, Sui Yuan Chang
, Tai Ling Chao
, Si Man Ieong
, Jun Tung Fang
,
Hsuan Cheng Huang
*
, Hsueh Fen Juan
*
*
此作品的通信作者
生物醫學資訊研究所
研究成果
:
Article
›
同儕審查
7
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
3C-like Protease (3CLpro)
33%
Antiviral Potency
33%
Bioinformatics
33%
COVID-19
66%
Drug Repurposing
100%
Drug Screening
66%
Enzyme Activity
33%
Feasible Strategy
33%
Inhibitory Effect
33%
Inhibitory Performance
33%
Multi-target
100%
Multiplex Assay
33%
Papain-like
33%
Plaque Reduction Assay
33%
Protease
33%
Savings Method
33%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Spike Receptor Binding Domain
33%
Therapeutic Potential
33%
Transmembrane Protease Serine 2 (TMPRSS2)
33%
U.S. Food
33%
Vaccine Development
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
33%
Coronavirinae
66%
Diseases
100%
Drug Repositioning
100%
Drug Screening
33%
Enzymes
33%
Infection
33%
Papain
33%
Proteinase
66%
Receptor
33%
SARS Coronavirus
100%
Serine Proteinase
33%
Tamoxifen
33%
Immunology and Microbiology
Bioinformatics
33%
COVID-19
66%
Drug Screening
33%
Enzyme Activity
33%
Infection
33%
Infectious Disease
33%
Protease
100%
Proteinase
100%
Receptor Binding
33%
Serine
33%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
33%